Cart
sales@molnova.com
Cdk2 Inhibitor II
CAS No. 222035-13-4
Cdk2 Inhibitor II( —— )
Catalog No. M34895 CAS No. 222035-13-4
Cdk2 Inhibitor II is a selective and potent CDK2 inhibitor50 at 60 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 136 | In Stock |
|
| 5MG | 202 | In Stock |
|
| 10MG | 306 | In Stock |
|
| 25MG | 511 | In Stock |
|
| 50MG | 714 | In Stock |
|
| 100MG | 977 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1934 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCdk2 Inhibitor II
-
NoteResearch use only, not for human use.
-
Brief DescriptionCdk2 Inhibitor II is a selective and potent CDK2 inhibitor50 at 60 nM.
-
DescriptionCDK2-IN-3 (compound 3) is a potent and selective CDK2 inhibitor with an 50 of 60 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number222035-13-4
-
Formula Weight395.23
-
Molecular FormulaC14H11BrN4O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (253.02 mM; Ultrasonic )
-
SMILESN(NC1=CC=C(S(N)(=O)=O)C=C1)=C2C=3C(NC2=O)=CC=C(Br)C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. S T Davis, et al. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science. 2001 Jan 5;291(5501):134-7. ?
molnova catalog
related products
-
Cirtuvivint
Cirtuvivint (SM08502) is a potent, orally active CDC-like kinase (CLK) inhibitor useful for the study of arthritis.
-
AG-024322
AG-024322 is a potent ATP-competitive inhibitor targeting pan-CDK, effectively inhibiting cell cycle kinases CDK1, CDK2, and CDK4 with Ki values in the 1-3 nM range (1-3 nM).
-
SNX7
SNX7 (WAY-323879) is an inhibitor of the cell cycle protein-dependent kinase inhibitor (CDKI) pathway.
